logo
Researchers warn planned C-section births — the most common surgery in the US — can increase risk of childhood cancers

Researchers warn planned C-section births — the most common surgery in the US — can increase risk of childhood cancers

Yahoo08-07-2025
Children born using planned Cesarean section procedures may have a heightened risk of developing certain childhood cancers, according to the researchers.
After studying the health of nearly 2.5 million children, members of the Swedish Karolinska Institutet found an increased risk of developing acute lymphoblastic leukemia during these events – and not in similar emergency 'C-section' procedures.
They're still working to understand why this is the case, but have identified possible factors that could help to explain. The researchers noted that babies in planned C-sections are not stressed or exposed to vaginal bacteria, as during emergency C-sections. Doctors perform a C-section when the health of the baby is at risk or when a vaginal delivery isn't possible or safe.
'C-sections are an important and often life-saving part of obstetric care. We don't want mothers to feel anxious about medically indicated C-sections. But when this result is combined with other study results showing that the risk of later asthma, allergies or type 1 diabetes increases in children born by planned C-section, there is reason to discuss C-sections that are not medically indicated," researcher Christina-Evmorfia Kampitsi said in a statement.
Kampitsi and her team found that of the nearly 376,000 children born in by C-section Sweden between 1982 to 1989 and 1999 to 2015, nearly 1,500 later developed leukaemia. The risk of acute lymphoblastic leukemia was 21 percent higher in children born by planned C-section compared with children born vaginally.
Furthermore, the risk of developing the most common form of acute lymphoblastic leukemia, known as B-cell acute lymphoblastic leukemia, was 29 percent higher in those born by planned C-section. The increased cancer risk was more pronounced in boys than in girls, and in the early years of a child's life.
Acute lymphoblastic leukemia is a type of blood and bone marrow cancer, and the most common type of cancer in children. It's also unclear what causes the DNA mutations that can lead to the cancer, but treatments result in a good chance for a cure, according to the Mayo Clinic. The American Cancer Society estimates there will be 6,100 new cases and 1,400 deaths this year due to the cancer in both U.S. children and adults.
The researchers emphasized that the risk of developing these cancers remains low, regardless of the mode of delivery.
The excess risk associated with planned C-sections corresponds to approximately one case of B-cell acute lymphoblastic leukemia annually, they said.
C-sections have become increasingly common in the U.S., accounting for about one in three births, according to Centers for Disease Control and Prevention data. Notably, maternal mortality has been rising in the U.S. in recent years, with as many as 84 percent of pregnancy-related deaths believed to be preventable, according to Yale Medicine.
There are 1.2 million C-sections performed every year, making it the 'most common major surgery performed in the United States,' according to Dr. Cindy Celnik, the chief medical officer of The Woman's Hospital of Texas.
"Fortunately, acute lymphoblastic leukemia is rare,' added Kampitsi. 'This means that many C-deliveries are needed to obtain a statistically significant result, and it is difficult to obtain such a large sample in a Swedish registry study. However, the results are close to significant, are in line with what previous studies have shown, and remain when we adjust for other relevant factors, which still makes them relevant.'
Kampitsi was the lead author of the findings, which were published on Friday in The International Journal of Cancer.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

FDA Announces Major Recall of Popular Chocolate Item
FDA Announces Major Recall of Popular Chocolate Item

Yahoo

time6 hours ago

  • Yahoo

FDA Announces Major Recall of Popular Chocolate Item

It's a good thing the U.S. Food and Drug Administration is staying on top of the latest recalls, because knowing about new recalls impacts people's lives. The sooner you find out about an item that falls under a recall, the quicker you can get rid of it and keep your friends and family safe. "A recall is a method of removing or correcting products that are in violation of laws administered by the Food and Drug Administration," the FDA notes. They add that a recall is a voluntary action taken by manufacturers and distributors to protect the health of the public and keep them away "from items that offer a "risk of injury or gross deception or are otherwise defective." Now, the FDA has announced a chocolate spread recall due to salmonella contamination. According to the Mayo Clinic, salmonellosis "is a common bacterial disease that affects the intestinal tract." The clinic adds that most people "develop diarrhea, fever and stomach (abdominal) cramps within 8 to 72 hours after exposure." The Cleveland Clinic adds that "salmonella is an infection with salmonella bacteria that causes diarrhea, fever and stomach pains." The recall is for Dubai chocolate spread, which is sold nationwide. World Market recalled its Emek Spread Pistachio Cacao Cream with Kadayif sold from June 11 to July 9, according to a press release from the FDA. The spread's jar is labeled with "Dubai" and contains similar ingredients to the Dubai chocolate bar, but with kadayif and pistachio paste. The product was also packaged in clear glass jar with the date code stamped on the top of the lid. Now, the recall has been raised to a Class 1 alert, which means a "reasonable probability" that injecting the spread could cause serious illness or even death, according to the FDA. The recall was announced after samples of the food item tested positive for salmonella, the FDA added. The good news is that no illnesses have been reported so far. Those who have the item are urged to throw it away as soon as possible or return it to World Market for a full Announces Major Recall of Popular Chocolate Item first appeared on Men's Journal on Jul 21, 2025 Solve the daily Crossword

Baby girl grows ‘micropenis' after laying on her dad's chest
Baby girl grows ‘micropenis' after laying on her dad's chest

New York Post

time17 hours ago

  • New York Post

Baby girl grows ‘micropenis' after laying on her dad's chest

A baby girl in Sweden reportedly sprouted a 'micropenis' after lying on her father's bare chest — turning a tender bonding moment into a bizarre biological blunder. And she's not the only one. A Swedish doctor is sounding the alarm, warning she's seen at least half a dozen similar cases in children. Here's what you need to know to make sure your child isn't next. 4 Skin-to-skin contact can help regulate the baby's body temperature, heart rate and breathing. barneyboogles – Often referred to as 'kangaroo care,' skin-to-skin contact is a common practice used to strengthen the bond between newborns and parents while supporting healthy early development. But in this case, that sweet ritual took a strange turn. After her birth, the Swedish baby girl was repeatedly placed on her father's bare chest — the same area where he had applied testosterone gel. The topical medication is commonly prescribed to men with hypogonadism, a condition in which the body doesn't produce enough sex hormones. It's more common than you might think. Research suggests that, after the age of 40, men's testosterone levels fall by about 1% each year, a biological process sometimes colloquially called 'manopause.' While hypogonadism can affect men of any age, studies suggest that roughly 40% of those over 45 and half of men in their 80s have clinically low testosterone. 4 Testosterone gel increases levels of the testosterone hormone in your body. mbruxelle – Over time, this drop can lead to a range of symptoms, including low sex drive, erectile dysfunction, fatigue, mood swings and muscle loss — issues that testosterone replacement therapy (TRT) can help treat. Unaware of the risk, the father's skin-to-skin contact inadvertently exposed his daughter to high levels of testosterone — triggering dramatic changes in her genitalia. Her parents noticed that her clitoris had begun to elongate, resembling a small penis, while her labia began to fuse, eventually looking similar to a male scrotum. Panicked, they brought their 10-month-old daughter to a doctor. Blood tests quickly identified the source. 4 Secondary exposure to testosterone gel in children can trigger adverse effects such as premature puberty. – 'I don't think people always understand how potent these treatments are,' Professor Jovanna Dahlgren, a pediatric endocrinologist at Sahlgrenska University Hospital, told local news outlet Göteborgs-Posten. 'The parents become completely desperate when they understand what has happened,' she added. The case, which occurred eight years ago, is one of at least six similar incidents Dahlgren has seen, all involving young children unintentionally exposed to hormone medication through close contact with a parent. In one case, she said, a 10-year-old boy developed breasts after coming into contact with estrogen cream his mother had been using. Fortunately, in the Swedish girl's case, her genitals began to shrink once her father stopped using the gel and the accidental exposure ceased. And while local media described the case as a 'micropenis,' experts note that's not technically accurate, as the term refers specifically to underdeveloped male genitalia — not virilized female anatomy. 4 Testosterone decline in men, common with age, can lead to side effects like erectile dysfunction. Kaspars Grinvalds – The story comes amid a surge in TRT popularity, including in the US, where prescriptions jumped from 7.3 million in 2019 to over 11 million last year, according to CBS News. High-profile names like Josh Duhamel, Sylvester Stallone, Joe Rogan — and even Health and Human Services Secretary Robert F. Kennedy Jr. — have gotten in on the hormone hack. But it's not just aging men fueling the trend. On TikTok, the hashtag 'TRT Before and After' has exploded with millions of views, showcasing ripped guys in their 20s and 30s boasting about about boosted energy levels and sex drives. Experts, however, warn TRT isn't without risks. Side effects can include acne, fluid retention, testicular shrinkage, reduced fertility and worsened sleep apnea, according to the Cleveland Clinic. TRT comes in several forms: pills, injections, patches, and gels. If you use the topical gel, the Mayo Clinic advises washing your hands thoroughly after application and rinsing the treated area before any skin-to-skin contact to avoid accidentally exposing others.

Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board
Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

Yahoo

time19 hours ago

  • Yahoo

Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

SYDNEY, July 22, 2025 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, 'Radiopharm' or the 'Company'), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, is pleased to announce the appointment of Dr Oliver Sartor, MD to the Company's Scientific Advisory Board (SAB). Dr Sartor is an internationally recognised medical oncologist and scientist specialising in prostate cancer and radiopharmaceutical therapies. He currently serves as Director of Radiopharmaceutical Clinical Trials and Chair of the Genitourinary Cancer Disease Group at the world-renowned Mayo Clinic, in Rochester, Minnesota. He was previously Laborde Professor of Medicine and Urology and Medical Director of Tulane Cancer Center in New Orleans under Tulane University School of Medicine. Dr Sartor has also held senior roles at LSU Health Sciences Center, Dana‑Farber/Harvard Medical School, and as Medical Oncology Co‑Chair of the GU Committee of NRG Oncology. Dr Sartor received his MD with honours from Tulane University School of Medicine in 1982, completed internal medicine residency at Tulane, and a medical oncology fellowship at the National Cancer Institute (NCI). Since 1990 he has focused on prostate cancer clinical research, authoring more than 500 peer‑reviewed publications and leading multiple pivotal Phase 3 trials that resulted in FDA approvals for therapies including samarium‑153 EDTMP, cabazitaxel, radium‑223, and PSMA‑targeted radioligand therapy. 'Dr Sartor brings an unparalleled depth of expertise in both clinical translation and radiopharmaceutical therapies,' said Riccardo Canevari, Managing Director and CEO of Radiopharm Theranostics. 'We're very honoured to welcome him to our SAB. His insight and leadership will be invaluable as we advance our radiopharmaceutical pipeline.' About Radiopharm Theranostics Radiopharm Theranostics is a clinical stage radiotherapeutics company developing a world-class platform of innovative radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. Radiopharm is listed on ASX (RAD) and on NASDAQ (RADX). The company has a pipeline of distinct and highly differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer. The clinical program includes one Phase 2 and three Phase 1 trials in a variety of solid tumor cancers including lung, breast, and brain metastases. Learn more at Authorized on behalf of the Radiopharm Theranostics Board of Directors by Executive Chairman Paul Hopper. For more information: Investors:Riccardo CanevariCEO & Managing DirectorP: +1 862 309 0293E: rc@ Anne Marie Fields Precision AQ (Formerly Stern IR) E: Media:Matt WrightNWR CommunicationsP: +61 451 896 420E: matt@ Follow Radiopharm Theranostics: Website – Twitter – Linked In – –

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store